Rankings
▼
Calendar
LGVN Q1 2020 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$18M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$812,000
47.5% margin
Operating Income
-$213,000
-12.5% margin
Net Income
-$213,000
-12.5% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
-7.3%
Cash Flow
Operating Cash Flow
-$398,000
Free Cash Flow
-$528,000
Stock-Based Comp.
$57,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$4M
Cash & Equivalents
-$2M
← FY 2020
All Quarters
Q2 2020 →